<DOC>
	<DOCNO>NCT01714687</DOCNO>
	<brief_summary>This post-market study aim compare health outcome Recurrent Acute Rhinosinusitis ( RARS ) patient treat balloon sinus dilation ( BSD ) versus medical management alone .</brief_summary>
	<brief_title>Comparison Balloon Sinuplasty In-Office Versus Medical Management Recurrent Acute Sinusitis Patients ( CABERNET )</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<criteria>19 year age great diagnosis recurrent acute rhinosinusitis suitable candidate officebased procedure willing able read sign inform consent remain compliant protocol study procedure able read understand English diagnosis chronic rhinosinusitis prior sinus surgery physician determine need ancillary procedure know immune deficiency , ciliary dysfunction and/or autoimmune disease clinically significant illness may interfere evaluation study participation clinical study 6 month prior study participation pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>